Several studies reported elevated levels of IL-6 in patients with respiratory diseases, such as asthma and COPD, in which the inflammatory status and the lung epithelial damage are well known (Rincon and Irvin, 2012; Bradford et al., 2017). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.